People: Charles River Laboratories International Inc (CRL.N)
Mr. David Ross Smith has been appointed as Chief Financial Officer, Corporate Executive Vice President, of the Company., effective April 26, 2017. He has served as our Corporate Executive Vice President and Chief Financial Officer since August 2015. He joined us as Corporate Vice President, Discovery Services through our acquisition of Argenta and BioFocus from Galapagos NV in March 2014 and was promoted to Corporate Senior Vice President, Global Discovery Services, in October 2014. At Galapagos, he served in various capacities, including as Chief Executive Officer of its Galapagos Services division and as Chief Financial Officer. Mr. Smith served as Chief Financial Officer for Cambridge University Hospitals from 2007 to 2013. Mr. Smith spent eight years at PricewaterhouseCoopers prior to joining AstraZeneca in 1997, where he spent the next nine years in various finance and business roles of increasingly greater responsibility.
|Total Annual Compensation, USD||533,815|
|Restricted Stock Award, USD||1,497,540|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,208,590|
|Fiscal Year Total, USD||3,239,940|